SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardinal Health Inc. – ‘8-K’ for 9/30/22

On:  Tuesday, 10/4/22, at 4:28pm ET   ·   For:  9/30/22   ·   Accession #:  721371-22-127   ·   File #:  1-11373

Previous ‘8-K’:  ‘8-K’ on / for 9/13/22   ·   Next:  ‘8-K’ on / for 11/4/22   ·   Latest:  ‘8-K’ on / for 4/23/24   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/04/22  Cardinal Health Inc.              8-K:1,9     9/30/22   11:1.6M

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     37K 
 2: EX-10.1     Material Contract                                   HTML   1.26M 
 6: R1          Cover Page                                          HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- cah-20220930_htm                    XML     21K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- cah-20220930_lab                      XML     67K 
 5: EX-101.PRE  XBRL Presentations -- cah-20220930_pre               XML     33K 
 3: EX-101.SCH  XBRL Schema -- cah-20220930                          XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0000721371-22-000127-xbrl      Zip    205K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  cah-20220930  
 i 0000721371 i false00007213712022-09-302022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM  i 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i September 30, 2022
 i Cardinal Health, Inc.
(Exact name of registrant as specified in its charter)
 i Ohio i 1-11373 i 31-0958666
(State or other
jurisdiction of incorporation)
(Commission
File Number)

(IRS Employer
Identification No.)
 i 7000 Cardinal Place,  i Dublin,  i Ohio  i 43017
( i 614)  i 757-5000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
 i Common shares (without par value) i CAH i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p








Item 1.01 Entry Into A Material Definitive Agreement.

On September 30, 2022, Cardinal Health Funding, LLC (“Funding”), a receivables financing subsidiary of Griffin Capital, LLC (“Griffin Capital”), a receivables financing subsidiary of Cardinal Health, Inc. (the “Company”), Griffin Capital, Wells Fargo Bank, N.A. (“WF”), Liberty Street Funding LLC (“Liberty Street”), The Bank of Nova Scotia (“BNS”), Atlantic Asset Securitization LLC (“Atlantic”), Credit Agricole Corporate and Investment Bank New York Branch (“Credit Agricole”), U.S. Bank National Association (“U.S. Bank”), PNC Bank, National Association (“PNC”), Bank of America, National Association (“BofA”), Victory Receivables Corporation (“Victory”) and MUFG Bank, LTD (“MUFG”) entered into a Sixth Amendment (the “Amendment”) to the Fourth Amended and Restated Receivables Purchase Agreement (as amended, the “Receivables Purchase Agreement”). The Receivables Purchase Agreement was entered into on November 1, 2013 by and among Funding, Griffin Capital, WF, PNC, BNS, Liberty, Victory, and MUFG (formerly, The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch), as Agent. Certain of the parties to the Receivables Purchase Agreement have changed since its execution.

The principal purposes of the Amendment are (1) to extend the term of the Company’s $1.0 billion committed receivables sales facility program (the “Facility”) from September 30, 2022 to September 30, 2025, (2) to add BofA as a participant in the Facility, (3) to remove Credit Agricole and U.S. Bank as participants from the Facility and (4) to replace the LIBOR-based interest rate benchmark provisions with interest rate benchmark provisions based on a daily term secured overnight financing rate for an interest period of one month. The Amendment is filed as Exhibit 10.1 to this Current Report on Form 8-K and the foregoing description is qualified by reference to the full text of the Amendment.

From time to time, the financial institutions that are parties to the Receivables Purchase Agreement or their affiliates have performed, and may in the future perform, various commercial banking, investment banking or other financial advisory services for the Company and its affiliates for which they receive customary fees and expenses. For example, WF and BofA serve as dealers under the Company’s commercial paper program and MUFG, BNS, WF, Credit Agricole, PNC and BofA or their affiliates currently act as members of the lending syndicate under the Company’s $2.0 billion revolving credit facility.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits
Exhibit
10.1
104
Cover Page Interactive Data File – the cover page iXBRL tags are embedded within the Inline XBRL document




Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc.
(Registrant)
Date:October 4, 2022By:/s/ PATRICIA M. ENGLISH
Patricia M. English
Chief Financial Officer



Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
9/30/25None on these Dates
Filed on:10/4/22
For Period end:9/30/22
11/1/13
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  Cardinal Health Inc.              424B5                  2:682K                                   Donnelley … Solutions/FA
 2/14/24  Cardinal Health Inc.              424B5                  1:658K                                   Donnelley … Solutions/FA
 8/15/23  Cardinal Health Inc.              10-K        6/30/23  118:14M
11/08/22  Cardinal Health Inc.              S-3ASR     11/08/22    6:462K                                   Donnelley … Solutions/FA
11/08/22  Cardinal Health Inc.              S-8        11/08/22   15:1.3M
11/04/22  Cardinal Health Inc.              10-Q        9/30/22   70:6.5M
Top
Filing Submission 0000721371-22-000127   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 10:17:30.3am ET